N-Side
Private Company
Total funding raised: $5.5M
Overview
N-SIDE is a specialized technology provider operating at the intersection of digital health, AI, and life sciences operations. The company has established itself as a leader in clinical supply chain optimization, serving a significant portion of the top 20 global pharmaceutical companies. By leveraging its proprietary AI and digital twin technology, N-SIDE addresses critical inefficiencies in clinical trials, helping sponsors reduce waste, lower costs, and accelerate development timelines. With over two decades of experience and a track record of optimizing thousands of trials, the company operates a hybrid business model offering both software products and expert services.
Technology Platform
AI-driven forecasting, planning, and optimization platform for clinical trial supply chains, featuring digital twin simulation and an integrated ecosystem (Lighthouse) for collaborative planning.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
N-SIDE competes in the clinical trial optimization space against broad enterprise software providers like Veeva and Oracle, which offer clinical operations suites, and other specialized vendors focusing on supply chain or interactive response technology (IRT). Its differentiation lies in its deep focus on AI-driven forecasting, digital twin simulation, and a hybrid model combining software with deep domain expertise.